Nipin (Nifedipine)

Nifedipine, the active ingredient in Nipin, is a calcium channel blocker presented as an oral tablet for oral use. It treats hypertension, angina pectoris and Raynaud's phenomenon in adult patients.\n\nGNH India supplies Nipin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nifedipine acts on the cardiovascular system to lower blood pressure and improve myocardial oxygen supply.\n\nHypertension: reduces systemic vascular resistance and lowers blood pressure.\nAngina pectoris: decreases cardiac workload and prevents chest pain episodes.\nRaynaud's phenomenon: enhances peripheral blood flow and reduces frequency of vasospastic attacks.

Nifedipine may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Headache\n- Flushing\n- Peripheral edema\n- Dizziness\n\nSerious or Rare Side Effects:\n- Severe hypotension\n- Allergic reactions such as rash or anaphylaxis

Before initiating therapy, clinicians should consider several safety measures.\n\nMonitor blood pressure regularly: ensure target levels are achieved without excessive drop.\nAvoid abrupt discontinuation: taper dose to prevent rebound hypertension.\nUse caution in hepatic impairment: dose adjustment may be required.\nAvoid concurrent strong CYP3A4 inhibitors: may increase nifedipine exposure.\nUse with caution in patients with heart failure: monitor for worsening symptoms.\nStore at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nifedipine can interact with other medicines, altering its effectiveness or safety.\n\nMajor Interactions (Avoid):\n- Grapefruit juice: markedly increases plasma concentrations.\n- Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may cause toxicity.\n- Concurrent use with other potent antihypertensives: risk of severe hypotension.\n\nModerate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce efficacy.\n- Diuretics: may enhance hypotensive effect.\n- Digoxin: may increase serum digoxin levels, requiring monitoring.